The structural profiles are close, with Jazz Pharmaceuticals carrying a narrow edge on stability. Medtronic still has the edge on stability, which keeps the comparison from looking entirely one-sided. On the market side, Jazz Pharmaceuticals is in better shape — its trend is intact while Medtronic's trend has broken down. That puts structure and market broadly in agreement — Jazz Pharmaceuticals's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
Stability points more clearly toward Medtronic plc, even if the broader score still leans toward Jazz Pharmaceuticals plc.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
The strongest overlap appears in investment intensity and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The structural gap is limited here, but current pricing still leans against Medtronic plc.
Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.
The stability gap is wide, with the stronger side looking materially steadier through time.
Medtronic plc still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.
The lead is built on both stability and growth — though stability still provides a counterweight.
Break down the JAZZ vs MDT comparison across all dimensions with the full interactive tool.
Explore how JAZZ and MDT each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.